cbdMD, Inc.YCBDNYSE
Loading
Year-over-year SG&A expense growth
Latest
-4.96%
↓ 160% vs avg
Percentile
P39
Within normal range
Streak
1 qtr
Consecutive growthRecovering
Average
8.33%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -4.96% |
| Q3 2025 | -7.37% |
| Q2 2025 | 9.38% |
| Q1 2025 | -0.93% |
| Q4 2024 | 21.40% |
| Q3 2024 | -24.90% |
| Q2 2024 | -7.54% |
| Q1 2024 | -11.45% |
| Q4 2023 | -9.85% |
| Q3 2023 | -10.49% |
| Q2 2023 | 5.11% |
| Q1 2023 | -30.40% |
| Q4 2022 | -3.52% |
| Q3 2022 | -4.42% |
| Q2 2022 | -26.44% |
| Q1 2022 | -8.16% |
| Q4 2021 | -6.77% |
| Q3 2021 | -8.52% |
| Q2 2021 | 12.71% |
| Q1 2021 | 15.90% |
| Q4 2020 | -4.33% |
| Q3 2020 | 32.47% |
| Q2 2020 | -33.81% |
| Q1 2020 | -1.06% |
| Q4 2019 | 23.21% |
| Q3 2019 | -11.68% |
| Q2 2019 | 100.76% |
| Q1 2019 | 313.09% |
| Q4 2018 | -9.67% |
| Q3 2018 | 5.23% |
| Q2 2018 | 56.25% |
| Q1 2018 | -44.47% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |